Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MPT-0118 |
Trade Name | |
Synonyms | MPT0118|MPT 0118 |
Drug Descriptions |
MPT-0118 inhibits mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1), which may result in reprogramming of regulatory T cells, potentially leading to inhibition of tumor growth (Journal for ImmunoTherapy of Cancer 2021; Vol 9, Issue Suppl 2; Annals of Oncology 32 (2021): S857). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C179694 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MPT-0118 | MPT-0118 | 0 | 1 |
MPT-0118 + Pembrolizumab | MPT-0118 Pembrolizumab | 0 | 1 |